BDBM425970 5-hydroxy-2-(4-fluorophenyl)-7-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)-butoxy)-chroman-4-one::US10513512, Compound P3

SMILES COc1ccccc1N1CCN(CCCCOc2cc(O)c3C(=O)CC(Oc3c2)c2ccc(F)cc2)CC1

InChI Key InChIKey=HTAKTCONXBKFJI-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 425970   

TargetD(2) dopamine receptor(Human)
Xuanwu Hospital of Capital Medical University

US Patent
LigandPNGBDBM425970(5-hydroxy-2-(4-fluorophenyl)-7-(4-(4-(2-methoxyphe...)
Affinity DataIC50: 57.3nMAssay Description:Objective: positive symptoms (hallucination, delusion, etc.) in patients with schizophrenia may be associated with dopamine (DA) hyperfunction in sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/24/2020
Entry Details
US Patent